Headache & Pain

Filter Your Results

 

News

 

Wireless Spinal Cord Stimulator Provides Relief from Chronic Pain

Friday, January 18, 2019—Clinical trial results showed that the world’s first wireless, fully programmable neuromodulation system (Freedom SCS System; Stimwave Technologies, Pompano Beach, FL) p…

Registry for Peripheral Nerve Stimulation for Pain Management Is Launched

Wednesday, January 16, 2019—The first registry related to peripheral nerve stimulation (PNS) for pain management is enrolling patients. The registry will collect long-term clinical data with the goal of …

Phase 3 Trial of Dioscorea japonica Extracts To Be Initiated for Treatment of Pain From Diabetic Neuropathy

Tuesday, January 08, 2019—The planned initiation of a phase 3 double-blind, placebo controlled, 12-week study of Dioscorea japonica extracts (NB-01; Neurobo, Boston, MA) for pain relief in pa…

Federal Supply Schedule Adds External Vagus Nerve Stimulator for Headache Prevention and Treatment

Tuesday, January 08, 2019—A noninvasive vagus nerve stimulation (nVNS) device (gammaCore; electroCore, Basking Ridge, NJU) has been award a 5-year Federal Supply Schedule medical equipment and supply c…

American Academy of Neurology Call for Uniformity in Brain Death Standards

Thursday, January 03, 2019—Noting that only 1 state, Nevada, has adopted legislation requiring use of medically accepted guidelines for determining brain death, the American Academy of Neurology (AAN) i…

New Drug Application Accepted for Combined Bupivacaine/Meloxicam for Post-Operative Pain

Wednesday, January 02, 2019—The Food and Drug Administration (FDA) has accepted a new drug application (NDA) for fixed-dose combined bupivacaine/meloxicam (HTX-011; Heron Therapeutics, San Diego, CA), an…

American Headache Society Releases Statement on Integrating New Treatments for Migraine Into Practice

Friday, December 21, 2018—To provide health care professionals with updated guidance on the use of novel preventive and acute treatments for migraine in adults, the American Headache Society (AHS) publ…

Long-Term Safety and Tolerability of Rimegepant for Treatment of Migraine

Thursday, December 13, 2018—Initial results from an ongoing, open-label safety study of the oral calcitonin gene-related peptide (CGRP) receptor antagonist, rimegepant, show that the drug may be effectiv…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC